Platinum-based inhibitors of amyloid-β as therapeutic agents for Alzheimer's disease
- 13 May 2008
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (19) , 6813-6818
Abstract
Amelyoid-β peptide (Aβ) is a major causative agent responsible for Alzheimer's disease (AD). Aβ contains a high affinity metal binding site that modulates peptide aggregation and toxicity. Therefore, identifying molecules targeting this site represents a valid therapeutic strategy. To test this hypothesis, a range of L-PtCl 2 (L = 1,10-phenanthroline derivatives) complexes were examined and shown to bind to Aβ, inhibit neurotoxicity and rescue Aβ-induced synaptotoxicity in mouse hippocampal slices. Coordination of the complexes to Aβ altered the chemical properties of the peptide inhibiting amyloid formation and the generation of reactive oxygen species. In comparison, the classic anticancer drug cisplatin did not affect any of the biochemical and cellular effects of Aβ. This implies that the planar aromatic 1,10-phenanthroline ligands L confer some specificity for Aβ onto the platinum complexes. The potent effect of the L-PtCl 2 complexes identifies this class of compounds as therapeutic agents for AD.Keywords
This publication has 25 references indexed in Scilit:
- Inhibition of Amyloid Fibril Formation by Polyphenols: Structural Similarity and Aromatic Interactions as a Common Inhibition MechanismChemical Biology & Drug Design, 2005
- Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease β‐amyloidThe FASEB Journal, 2004
- Characterizing bathocuproine self‐association and subsequent binding to Alzheimer's disease amyloid β‐peptide by NMRJournal of Peptide Science, 2003
- Neurotoxic, Redox-competent Alzheimer's β-Amyloid Is Released from Lipid Membrane by Methionine OxidationJournal of Biological Chemistry, 2003
- Long-term potentiation: outstanding questions and attempted synthesisPhilosophical Transactions of the Royal Society B: Biological Sciences, 2003
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivoNature, 2002
- Alzheimer's Disease Amyloid-β Binds Copper and Zinc to Generate an Allosterically Ordered Membrane-penetrating Structure Containing Superoxide Dismutase-like SubunitsJournal of Biological Chemistry, 2001
- Steric Crowding and Redox Reactivity in Platinum(II) and Platinum(IV) Complexes Containing Substituted 1,10-PhenanthrolinesInorganic Chemistry, 1996
- Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatinNature, 1995